10/04/2023
31/08/25 It is hard to keep up with all the positive news from RMR drilling recently and very heavy trading last Friday. When the markets open tmoz the buy price will be 0.42p and expect more brisk trading and a possible rise to 0.5p or beyond which will mean that all current holders of stock will be in profit. An update from the company is due very soon too, maybe by end of week.
29/10/25 Two new floats on the LSE are imminent which are Shawbrook Group and Princes Group
23/10/25 Rome Resources said that it hopes to announce the maiden mineral resource estimate from the Mont Agona and Kalayi prospects b y the end of October 2025
08/09/25 JOURNEO touched a fiver today even sooner than I expected.
01/09/25 JOURNEO is within a few pence of its all time high of 440p so the the next big contract win could take it to 450p or beyond.
15/10/24 Rome resources (RMR) has completed seven drill holes on Kalayi and one on Mont Agoma with three drill rigs currently drilling across the Project. A fourth rig is in the process of being transported by helicopter from the base at Osokare. The first batch of diamond core samples have been prepared for export at Congolese Analytical Laboratory. Results expected later this month.
22/10/24 An update on drilling progress at Mont Agoma Prospect has indicated that there is a significant increase in width and depth of the mineralisation in the southeasternmost holes. Over 46 million shares were traded today. Apart from those who bought on the first day during the intra high of 0.68p, all investors are well in profit now.
26/10/24 Applied Nutrition floats on Tuesday 29th @ 140p. Will the milkshake market collapse now that those who throw one on frogface are likely to get a severe jail sentence? But seriously, I am not impressed by this company. However, Wayne and Coleen are investing. Shares struggled in conditional dealing last Thursday and Friday.
26/10/24 SELKIRK GROUP will float on AIM in a few days advised by Zeus Capital. It will take stakes in both private and Aim companies specifically within the consumer, technology and digital media sector. The initial funds raised will be used for the purposes of funding operating expenses, undertaking due diligence on potential target acquisitions and funding costs associated with such acquisitions. It will seek out a AIM company with a market cap in the range £30m to £1 billion. This could be via a reverse takeover. The main man is executive chair Iain McDonald. The website selkirkplc.com will be in operation from day of admission to AIM.
29/10/24 European Green Transition has announced positive results from initial Olserum Drilling Results. Remainder of results expected this quarter subject to lab turnaround times.
04/11/24 Selkirk Group will float on AIM on Thursday 7th November 2024. The size of the primary offer will be 7.5 million. You will only be able to buy from Thursday onwards.
05/11/24 By 9am today Rosebank Industries buy price reached a new high of 850p so every previous investor is now in profit.
07/11/24 SELKIRK GROUP floated on AIM today at 2.4p per share.
19/11/24 Applied Nutrition has dropped to 137.5p today so it was overpriced at float and is not much of a growth stock
09/12/24 Poolberg Pharma presented on Dec 7th at the 66th American Society of Hematology (ASH) Annual Meeting in San Diego POLB 001 pre-clinical study data. All doses of POLB 001 significantly reduced clinically observed cytokine release syndrome scores. POLB 001 treatment showed statistically significant reductions in key cytokines. Positive results reinforce the use case for POLB 001 in the prevention and treatment of cancer immunotherapy-induced.
11/12/24 hVIVO said on 09/12/24 it has struck a £11.5 million respiratory syncytial virus con biophafrmatract with an existing top tier global pharma client. hVIVO will test the client's antiviral candidate using its RSV human challenge study model due to commence at Canary Wharf with revenue aimed to be recognised across 2025 and 2026. hVIVO now works with 4 of the top ten global pharma companies.
28/01/25 Despite recent share price drops hVIVO is a world class company and worth sticking with. This has been proven today when it has announced that it has signed a Letter of Intent with ILiAD Biotech to conduct a pivotal stage three human challenge study for Bordetella Pertussis, a significant milestone in vaccine development. Whooping Cough remains a significant global concern and causes many deaths. The trial will begin in the second half of 2025.
Rome Resources (RMR) 0n 27/12/24 announced the receipt of subscription funds from Stanvic which will help with exploration costs.
27/12/24 Today ROSE reached a new high of 870p.
27/12/24 Today Amcomri reached a new high of 59p.
10/01/25 POLB US biopharma giant GILEAD announced that it is hoping to merge its Austrian quoted subsidiary HOOKPIA with POLB and then transfer the combined entity onto Nasdaq. Cathal Friel has given his blessing to such a merger. If it goes ahead, POLB will no longer be quoted on AIM so investors will need to fill in a W8-BEN form as otherwise they will not be able to trade the shares.
This is quite easy to do with your existing broker and should be done asap.
28/01/25 RC Fornax is a forthcoming new issue on AIM in early February It is an engineering consultancy with a focus on the UK defence industry. It was co-founded in 2020 by two former RAF pilots Paul Reeves and Daniel Clark. Check out its website at rcfornax.co.uk
28/01/25 hVIVO today announced that it has acquired two clinical
trial units in Germany for a cash consideration of ten million euro. A 91 bed unit in Mannheim and a 26 bed unit Kiel for ten million Euro which will establish a significant European foot for hVIVO.
Also, a trading statement today reported that revenue this year increased to £62.7 million. The company forecast that revenue including the two acquisitions should reach £100 by 2028.
20/11/25 hVIVO today announced that since September it has won £5m in CRS contracts in Germany.
20/02/25 Since floating at 32.5p RC Fornax has risen slightly and price today is 34p.
20/02/25 At last Rosebank has announced a possible acquisition which is Electrical Components International Inc. As per AIM rules the shares have been temporarily suspended
12/03/25 ROSE announced that due to market volatility it has withdrawn its offer for ECI and shares are no longer suspended.
22/02/25 Global Data got a great plug in the Sunday Times last Sunday. The company is shortly moving from AIM to the Main Market
24/02/25 Three new floats on AIM shortly.
AssetCo to be renamed as River Global on March 7th.
One Health Group on March 20th.
Wellnex LIfe early March.
12/05/25 RCFORNAX has opened its new office in Bristol and the share price reached 40p today.
MONZO is rumoured to float on the LSE in 2026.
MONEYBOX is looking at a valuation of £6 billion when it floats on the LSE which is very expensive for this fintech company.
02/06/25 ROME is getting good results from its three drills.
02/06/25 ROSEBANK has again suspended its shares on AIM as talks to acquire ECI are back on again.
04/06/25 MICROSALT(SALT)has varied from 32p to 105p over a year and is currently 85p to buy. I have never bought this AIM stock but will be tempted if it drops below 70p again.
06/06/25 JOURNEO has reached a new high.
06/06/25 A well known pundit said to sell BILLINGTON at 375p recently but it is now 430p with a 25p dividend due to be paid next week.
08/06/25 Oliver Shah in today's Sunday Times praised ROSEBANK for raising £1.1 Billion from shareholders including Blackrock for its proposed bid for ECI. The shares should be free from their temporary suspension soon and expect a bounce upwards.
12/06/25 The bounce yesterday was downwards but it seems to have settled today. ECI was a big acquisition to take on and Rosebank needs to find a smaller one soon. Let's see how the forthcoming AGM votes.
04/07/25 The ROSE agm voted over 98 per cent in favour though the share price has dropped a bit further.
20/11/25 ROSE trading update today on ECI acquisition was very positive and lifted the share price. ROSE confirmed that it is moving from AIM to the main market of LSE in Q2 of 2026.
Rome Resources reported last week further encouraging results from its ongoing drillings at the Bisie North Project in the Eastern part of the DRC.
14/07/25 ALBA has entered into an agreement to acquire a majority stake in the Motzifeldt Critical Metals Project in Southern Greenland and has raised £550,000 before costs to progress work.
27/12/25 RMR is expected to start drilling in January with good expectations.
27/12/25 ROSE is expected to make a second acquisition in 2026.
